Page 27 - Read Online

Page 1160 Brettrager et al. Cancer Drug Resist 2019;2:1153-63 I http://dx.doi.org/10.20517/cdr.2019.91

DECLARATIONS
Acknowledgments
We want to thank the present and past van Waardenburg lab-members and our collaborators for
contributing to increase our knowledge of Tdp1 and Topoisomerases and Ms. Lisa Park for critical reading
and editing of this manuscript. Our apologies to colleagues whose work we did not mention, due to space
limitations. RCAMvW greatly appreciates the current and past financial support from the UAB Department
of Pharmacology and Toxicology, UAB O’Neil Comprehensive Cancer center, UAB ACS-IRG Junior Faculty
Development, DOD-OCRP pilot award, UAB School of Medicine, the Norma Livingston Ovarian Cancer
Foundation and the Alabama Drug Discovery Alliance.

Authors’ contributions
Collected data, wrote the review and edited the revision: Brettrager EJ, van Waardenburg RCAM

Availability of data and materials
Not applicable.

Financial support and sponsorship
RCAMvW was in part funded by American Cancer Society UAB ACS-IRG Junior Faculty Development
Grant (ACS-IRG-60-001-53); Department of Defense OCRP pilot award W81XWH-15-1-0198; and the
National Institutes of Health Cancer Center Core Support Grant (P30CA013148).

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2019.

REFERENCES
1. Interthal H, Pouliot JJ, Champoux JJ. The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamily.
Proc Natl Acad Sci U S A 2001;98:12009-14.
2. Pouliot JJ, Yao KC, Robertson CA, Nash HA. Yeast gene for a Tyr-DNA phosphodiesterase that repairs topoisomerase I complexes.
Science 1999;286:552-5.
3. Yang SW, Burgin AB Jr, Huizenga BN, Robertson CA, Yao KC, et al. A eukaryotic enzyme that can disjoin dead-end covalent
complexes between DNA and type I topoisomerases. Proc Natl Acad Sci U S A 1996;93:11534-9.
4. Comeaux EQ, van Waardenburg RC. Tyrosyl-DNA phosphodiesterase I resolves both naturally and chemically induced DNA adducts
and its potential as a therapeutic target. Drug Metab Rev 2014;46:494-507.
5. Ben Hassine S, Arcangioli B. Tdp1 protects against oxidative DNA damage in non-dividing fission yeast. EMBO J 2009;28:632-40.
6. Das BB, Dexheimer TS, Maddali K, Pommier Y. Role of tyrosyl-DNA phosphodiesterase (TDP1) in mitochondria. Proc Natl Acad Sci
U S A 2010;107:19790-5.
7. Fam HK, Chowdhury MK, Walton C, Choi K, Boerkoel CF, et al. Expression profile and mitochondrial colocalization of Tdp1 in
peripheral human tissues. J Mol Histol 2013;44:481-94.
8. Al Abo M, Sasanuma H, Liu X, Rajapakse VN, Huang SY, et al. TDP1 is critical for the repair of DNA breaks induced by
sapacitabine, a nucleoside also targeting ATM- and BRCA-deficient tumors. Mol Cancer Ther 2017;16:2543-51.
9. Alagoz M, Wells OS, El-Khamisy SF. TDP1 deficiency sensitizes human cells to base damage via distinct topoisomerase I and PARP
mechanisms with potential applications for cancer therapy. Nucleic Acids Res 2014;42:3089-103.
10. Huang SY, Murai J, Dalla Rosa I, Dexheimer TS, Naumova A, et al. TDP1 repairs nuclear and mitochondrial DNA damage induced by
chain-terminating anticancer and antiviral nucleoside analogs. Nucleic Acids Res 2013;41:7793-803.